Manuscripts

Search by keyword, year, or author name.

Showing 1554 manuscripts.

Development of resistence mutations in women receiving standard antiretrovial therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of Pediatric AIDS Clinical Trials Group P316.

Coleen Cunningham, Marie-Laure Chaix, Claire Rekacewicz, Paula Britto, Christine Rouzioux, Richard D. Gelber, Alejandro Dorenbaum, Jean-Francois Delfraissy, B. Brazin, Lynne M. Mofenson, John L. Sullivan, John P. Sullivan. Development of resistence mutations in women receiving standard antiretrovial therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of Pediatric AIDS Clinical Trials Group P316.. Journal of Infectious Diseases. 2002. 186: 181-8.

Year

2002

Journal

Journal of Infectious Diseases

Persistent HIV-1 DNA in PBNC of Children on HIghlyActive Antiretroviral Therapy Despite Prolonged Suppression of Plasma HIV-1 RNA.

A. Saitoh, Terence Fenton, Karen Hsia, Christine Powell, Cindy Christopherson, Courtney V. Fletcher, Stuart E. Starr, Stephen A. Spector. Persistent HIV-1 DNA in PBNC of Children on HIghlyActive Antiretroviral Therapy Despite Prolonged Suppression of Plasma HIV-1 RNA.. Journal of Infectious Diseases. 2002. 185: 1409-16.

Year

2002

Journal

Journal of Infectious Diseases

Lack of improvement in growth in HIV-infected children receiving ritonavir-containing highly active antiretroviral therapy

Sharon Appelbaum Nachman, Jane C. Lindsey, Stephen Ira Pelton, Lynne M. Mofenson, Ram Yogev. Lack of improvement in growth in HIV-infected children receiving ritonavir-containing highly active antiretroviral therapy. Archives of Pediatrics and Adolescent Medicine. 2002. 156: 497-503.

Year

2002

Journal

Archives of Pediatrics and Adolescent Medicine

Nevirapine pharmacokinetics in pregnant women and in their infants after in utero exposure.

Mark Mirochnick, Suzanne Siminski, Terence Fenton, M. Lugo, John L. Sullivan. Nevirapine pharmacokinetics in pregnant women and in their infants after in utero exposure.. Journal of Infectious Diseases. 2002. 2: 181-8.

Year

2002

Journal

Journal of Infectious Diseases

Rapid and sensitive oligonucleotide ligation assay for detection of mutations in human immunodeficiency virus type 1 associated with high-level resistance to protease inhibitors

Ingrid A. Beck, Madhumita S. Mahalanabis, G. Pepper, A. Wright, Scott Hamilton, E. Langston, Lisa M. Frenkel. Rapid and sensitive oligonucleotide ligation assay for detection of mutations in human immunodeficiency virus type 1 associated with high-level resistance to protease inhibitors. Journal of Clinical Microbiology. 2002. 40: 1413-9. PMID: 11923366

Year

2002

Journal

Journal of Clinical Microbiology

Comparison of human immunodeficiency virus antigens as stimulants for lymphocyte proliferation assays

John L. Schmitz, Thomas Denny, Ambrosia Garcia-Louzao, Janet L. Lathey. Comparison of human immunodeficiency virus antigens as stimulants for lymphocyte proliferation assays. Clinical and Diagnostic Laboratory Immunology. 2002. 9: 525-9.

Year

2002

Journal

Clinical and Diagnostic Laboratory Immunology

Concentration-controlled compared with conventional antiretroviral therapy for HIV infection

Courtney V. Fletcher, Peter Anderson, Thomas N Kakuda, Timothy Schacker, W. Keith Henry, Cynthia R. Gross, Richard Brundage. Concentration-controlled compared with conventional antiretroviral therapy for HIV infection. AIDS. 2002. 16: 551-60.

Year

2002

Journal

AIDS

Stavudine, Nevirapine, and Ritonavir in Stable Antiretroviral Therapy-Experienced HIV-Infected Children (Pediatric AIDS Treatment Group Protocol 338 Step 2)

Ram Yogev, Sophia S. Lee, Andrew A. Wiznia, Sharon Appelbaum Nachman, Kenneth Stanley, Stephen Ira Pelton, Lynne M. Mofenson, Susan A. Fiscus, Eleanor Jimenez, Mobeen H. Rathore, Elizabeth (Betsy) Smith, Kenneth McIntosh. Stavudine, Nevirapine, and Ritonavir in Stable Antiretroviral Therapy-Experienced HIV-Infected Children (Pediatric AIDS Treatment Group Protocol 338 Step 2). Pediatric Infectious Disease Journal. 2002. 2: 119-25.

Year

2002

Journal

Pediatric Infectious Disease Journal

Two-Dose Intrapartum/Newborn Nevirapine and Standard Antiretroviral Therapy to Reduce Perinatal HIV Transmission

Alejandro Dorenbaum, Coleen Cunningham, Richard D. Gelber, Mary Culnane, Lynne M. Mofenson, Paula Britto, Claire Rekacewicz, Marie Louise Newell, Jean-Francois Delfraissy, Bethann Cunningham-Schrader, Mark Mirochnick, John L. Sullivan. Two-Dose Intrapartum/Newborn Nevirapine and Standard Antiretroviral Therapy to Reduce Perinatal HIV Transmission. The Journal of the American Medical Association. 2002. 288: 189-198.

Year

2002

Journal

The Journal of the American Medical Association

Efavirenz liquid Formulation in human immunodeficiency virus-infected children.

Stuart E. Starr, Courtney V. Fletcher, Stephen A. Spector, Richard Brundage, Florence H. Yong, Steven D. Douglas, Patricia M. Flynn, Mark W. Kline, Patricia M. Flynn. Efavirenz liquid Formulation in human immunodeficiency virus-infected children.. Pediatric Infectious Disease Journal. 2002. 21: 659-63.

Year

2002

Journal

Pediatric Infectious Disease Journal